Biotech's Perfect Storm

Karberg, Sascha

doi:10.1016/j.cell.2009.07.026

Cited by 5 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The formation of spin-off firms originated from UoC has been a method of expansion of SF. Furthermore, Cambridge is known as a major pharma/biotech hub in the UK [53,54]. Basically, due to their close proximity and their historical connection, UoC can potentially contribute to the growth of the SF cluster by providing solutions to their business problems, leading to the generation of joint patents.…”

Section: Hypothesismentioning

confidence: 99%

Evaluation of Technological Knowledge Transfer between Silicon Fen Firms and University of Cambridge Based on Patents Analysis

Rezaei

Kamali

2022

Journal of Open Innovation: Technology, Market, and Complexity

View full text Add to dashboard Cite

Silicon Fen (SF) is a cluster of high-tech firms located around the University of Cambridge (UoC) in the UK. This article, for the first time, investigates the technological bonds between SF firms and UoC based on patent analysis covering the period of 1999–2021. We provide a short history of SF, highlighting its early formation and growth, and the role of spin-off firms on its evolution. We employ joint patents generated by UoC and various business sectors of SF to calculate the values of technological collaboration strength (TCS). It is found that the majority of joint patents (61%) are generated by the Pharma/Biotech sector of SF with the highest value of TCS (16.45 × 10−3). Moreover, the patent’s economic values across various business disciplines in SF are calculated based on the total counts of citations. Our observations suggest that senior university academics making spin-off firms in a business cluster around their university can effectively facilitate university–firm technological collaboration. Furthermore, the relatively strong technological bond between UoC and the Pharma/Biotech sector of SF is confirmed to be influenced by the collaboration of the university with its own spin-off firms rather than large independent firms in SF. The outcomes of this research contribute to the knowledge of the collaboration between a main research university and a cluster of firms located in its geographical proximity.

show abstract

Section: Hypothesismentioning

confidence: 99%

Evaluation of Technological Knowledge Transfer between Silicon Fen Firms and University of Cambridge Based on Patents Analysis

Rezaei

Kamali

2022

Journal of Open Innovation: Technology, Market, and Complexity

View full text Add to dashboard Cite

show abstract

The most transformative drugs of the past 25 years: a survey of physicians

Kesselheim

Avorn

2013

Nat Rev Drug Discov

View full text Add to dashboard Cite

Strategic and legislative efforts to catalyse pharmaceutical innovation may be hampered by a lack of consensus over what characterizes an innovative drug. To help clarify this issue, we conducted an extensive survey on transformative drug development, involving ∼180 expert physicians based at 30 leading US academic medical centres, covering 15 medical specialties. In an iterative Delphi process, the survey participants narrowed a list of all new drugs approved in their fields in the past 25 years and reached consensus over those that they considered to be most transformative, which are presented in this article. Participants were also asked how various factors affected their opinion; they most often invoked the effectiveness and superiority of the drugs over existing alternatives when identifying transformative drug innovation.

show abstract